Trial · NCT07600385
A Study to Evaluate the Efficacy and Safety of UI022/UI023
NCT07600385, Phase 3, Completed, Korea United Pharm. Inc.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study to Evaluate the Efficacy and Safety of UI022/UI023. Trials, record NCT07600385. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07600385
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study to Evaluate the Efficacy and Safety of UI022/UI023
- NCT number
- NCT07600385
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 260 participants, actual
- Lead sponsor
- Korea United Pharm. Inc.
- Conditions
- Peripheral Arterial Disease
- Interventions
- UI022 or UI023 and co-administration of matching placebo, UIC201604 or UIC201801 and co-administration of matching placebo
- First posted
- 2026-05-20
- Last updated
- 2026-05-20
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline in KPAQ Summary Score at Week 24 | Baseline and Week 24 | |
| Secondary | Change From Baseline in KPAQ Summary Score at Weeks 4, 8, and 12 | Baseline, Week 4, Week 8, and Week 12 | |
| Secondary | Change From Baseline in KPAQ Domain Scores at Weeks 4, 8, 12, and 24 | Baseline, Week 4, Week 8, Week 12, and Week 24 | |
| Secondary | Change From Baseline in 100-mm VAS Score for Lower Limb Pain at Weeks 4, 8, 12, and 24 | Baseline, Week 4, Week 8, Week 12, and Week 24 | |
| Secondary | Improvement Rate of Lower Limb Ischemic Symptoms at Weeks 4, 8, 12, and 24 | Week 4, Week 8, Week 12, and Week 24 | |
| Secondary | Improvement of Lower Limb Ischemic Symptoms Based on Participant Global Assessment at Weeks 4, 8, 12, and 24 | Week 4, Week 8, Week 12, and Week 24 | |
| Secondary | Change From Baseline in Initial Claudication Distance Using the Treadmill Test at Weeks 12 and 24 | Baseline, Week 12, and Week 24 | |
| Secondary | Change From Baseline in Functional Claudication Distance Using the Treadmill Test at Weeks 12 and 24 | Baseline, Week 12, and Week 24 | |
| Secondary | Change From Baseline in Absolute Claudication Distance Using the Treadmill Test at Weeks 12 and 24 | Baseline, Week 12, and Week 24 | |
| Secondary | Change From Baseline in Ankle-Brachial Index at Weeks 12 and 24 | Baseline, Week 12, and Week 24 |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 42704575 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07600385
GET https://conductscience.org/api/trials/v1/NCT07600385/registered